FMP

FMP

Enter

LIVN - LivaNova PLC

photo-url-https://images.financialmodelingprep.com/symbol/LIVN.png

LivaNova PLC

LIVN

NASDAQ

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.

47.68 USD

0.06 (0.126%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. Vladimir A. Makatsaria

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep ap...

CIK

0001639691

ISIN

GB00BYMT0J19

CUSIP

G5509L101

Address

20 Eastbourne Terrace

Phone

44 20 3325 0660

Country

GB

Employee

2,900

IPO Date

Oct 19, 2015

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

LIVN Financial Summary

CIK

0001639691

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

G5509L101

ISIN

GB00BYMT0J19

Country

GB

Price

47.68

Beta

1.01

Volume Avg.

477.93k

Market Cap

2.59B

Shares

-

52-Week

43.15-64.475

DCF

-13.94

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

110.88

P/B

-

Website

https://www.livanova.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest LIVN News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep